Suraksha Diagnostic Delivers Robust Q2 and H1 FY27 Results Driven by Margin Expansion
Suraksha Diagnostic Ltd · Press Release · 13 Nov 2026, 12:16 am
Suraksha Diagnostic Delivers Robust Q2 and H1 FY27 Results Driven by Margin Expansion Suraksha Diagnostic reported strong Q2 FY27 performance with total income rising 26% YoY to ₹1,005.75 million, EBITDA jumping 45% YoY to ₹363.17 million (margin expanding 500 bps to 36.7%), and PAT surging 69% YoY to ₹149.50 million. For H1 FY27, total income grew 24% YoY to ₹1,893.09 million and PAT rose 54% YoY to ₹277.96 million. Per corrected operational metrics, Q2 total tests grew 9% YoY to 2.40 million, while average revenue per test increased 15% YoY to ₹412, supported by network expansion of five new centres.
Original exchange filing (PDF)
More announcements from Suraksha Diagnostic Ltd
- Intimation of the audio recording of Analysts/Institutional Investors/Organisations meet- ''Earning Call'' for the quarter and half year ended 30 September 2026 · 13 Nov 2026
- Investor Presentation for Quarter and Half Year ended 30 September 2026 Q2 FY 2026-27 · 13 Nov 2026
- Clarification regarding Non-Publication of Newspaper Advertisement in "Businee Standard" Newspaper of Pune and Ahemdabad region under Regulation 47 of SEBI(LODR) regulation 2015 · 12 Nov 2026
- Corrigendum to the Press Release-Interview published in the Times of India dated November 11,2026 regarding Financial Performance for the Quarter and Half Year ended September 30, 2026 · 11 Nov 2026
- Results-Financial Results for Quarter and Half Year ended 30 September 2026 · 11 Nov 2026
- Press Release in respect of Unaudited(Standalone & Consolidated) Financial Results for the quarter ended 30th September 2026 · 10 Nov 2026
- Outcome of Board Meeting held today i.e. 10th November 2026 · 10 Nov 2026
- Outcome of Board Meeting held today i.e. 10th November 2026 · 10 Nov 2026
